As Omicron cases rise, EMA backs early use of Pfizer’s Paxlovid

The EMA’s human medicines committee has said that EU member states can start to offer Pfizer’s oral antiviral Paxlovid as a treatment for people with COVID-19 outside hospital, ahead of a formal approval for the drug.